Calendar

RECRUITINGphase readoutNCT06100237: Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Sponsor: Carl Ola Landgren, MD, PhD. Phase: PHASE2. Conditions: Multiple Myeloma

full page →ctgov ↗

TERMINATEDphase readoutNCT06560645: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Sponsor: Prelude Therapeutics. Phase: PHASE1. Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Carcinoma, SMARCA4 Mutation, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Squamous Cell Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT06011733: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis

full page →ctgov ↗

COMPLETEDphase readoutNCT06151847: Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

Sponsor: University of Kansas Medical Center. Phase: PHASE2. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Unresectable Melanoma

full page →ctgov ↗

COMPLETEDphase readoutNCT03986047: Effect of Thermal Therapy and Exercises on Acute Low Back Pain

Sponsor: Laval University. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07548658: Mind Mapping: Impact on Critical Thinking and Problem-Solving Skills

Sponsor: Gazi University. Phase: NA. Conditions: Mind Mapping, Nursing Students, Critical Thinking

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07543458: Therapeutics for Moderate and Severe Dengue

Sponsor: Oxford University Clinical Research Unit, Vietnam. Phase: PHASE3. Conditions: Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA Virus Infections, Hemorrhagic Fever

full page →ctgov ↗

RECRUITINGphase readoutNCT06662058: Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Sponsor: Emory University. Phase: NA. Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Metastatic Paranasal Sinus Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Paranasal Sinus Squamous Cell Carcinoma, Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Paranasal Sinus Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8

ACTIVE_NOT_RECRUITINGphase readoutNCT05864248: Feasibility Study SA of the Supira System for HRPCI

Sponsor: Supira Medical. Phase: NA. Conditions: Heart Diseases, Coronary Artery Disease (CAD), Heart Failure

full page →ctgov ↗

COMPLETEDphase readoutNCT06912555: Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Type 2 Diabetes, Overweight or Obesity, PreDiabetes

full page →ctgov ↗

RECRUITINGphase readoutNCT07415655: Modulation of Cerebral Ischemia by Albumin

Sponsor: University Hospital Hradec Kralove. Phase: PHASE2. Conditions: Ischemic Stroke

full page →ctgov ↗

RECRUITINGphase readoutNCT06246955: Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

Sponsor: Mayo Clinic. Phase: NA. Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗

RECRUITINGphase readoutNCT06843226: A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue

Sponsor: Takeda. Phase: . Conditions: Dengue Fever

full page →ctgov ↗

RECRUITINGphase readoutNCT07420478: TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Autism Spectrum Disorder, PTSD and Trauma-related Symptoms, Autism, Trauma and Stressor Related Disorders, Mental Health Services

full page →ctgov ↗

RECRUITINGphase readoutNCT07164378: International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

Sponsor: VisionCare, Inc.. Phase: NA. Conditions: Age - Related Macular Degeneration (AMD)

full page →ctgov ↗

RECRUITINGphase readoutNCT06620185: GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Sponsor: Imperial College London. Phase: NA. Conditions: Influenza

full page →ctgov ↗

RECRUITINGphase readoutNCT06680843: Characterization of Human Immune Signatures to Zoonotic Virus Exposure in Cambodia

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Immunity, Humoral

full page →ctgov ↗

COMPLETEDphase readoutNCT07616843: STANDARDIZATION OF THE PROTOCOL FOR ATTENUATION COEFFICIENT MEASUREMENT

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Liver Steatosis

full page →ctgov ↗

COMPLETEDphase readoutNCT03850743: Biomarker Signatures of the Sleep-pain Enigma

Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: . Conditions: Post Surgical Pain and Sleep Impairment

full page →ctgov ↗

RECRUITINGphase readoutNCT07441343: Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults

Sponsor: Dr. Chris McGlory, PhD. Phase: NA. Conditions: Sarcopenia, Aging, Frailty

full page →ctgov ↗

RECRUITINGphase readoutNCT07377643: IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.. Phase: PHASE3. Conditions: HER2-positive Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT01942343: Akathisia in Post Operative Outpatients Surgery

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Akathisia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07642843: CM336 for Active Sjogren's Syndrome Study

Sponsor: Keymed Biosciences Co.Ltd. Phase: PHASE1. Conditions: Primary Sjögren's Syndrome (pSS)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06967415: Comparison of Pain, Sensitisation, Function and Quality of Life According to Stenosis Degree in Chronic Neck Pain

Sponsor: Izmir Democracy University. Phase: NA. Conditions: Central Sensitisation, Cervical Spine Stenosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07054515: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Sponsor: Azafaros B.V.. Phase: PHASE3. Conditions: Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06924515: The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

Sponsor: Mingjian Ge. Phase: NA. Conditions: VATS, Lung Hernia

full page →ctgov ↗

RECRUITINGphase readoutNCT06159335: 18F-FLUC PET/MR in Patients With Brain Mets

Sponsor: University of Wisconsin, Madison. Phase: PHASE3. Conditions: Brain Metastasis, Radiation Therapy, Immunotherapy, Active

full page →ctgov ↗

COMPLETEDphase readoutNCT04197908: EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Acute Cholecystitis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07210125: Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Sponsor: Kelley-Ross & Associates, Inc.. Phase: PHASE4. Conditions: HIV

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07423325: Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor.

Sponsor: NovoBliss Research Pvt Ltd. Phase: NA. Conditions: Dry and Sensitive Skin

full page →ctgov ↗

RECRUITINGphase readoutNCT05274425: A 24-week rPMS Study in Real-world Setting for Enerzair

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Asthma

full page →ctgov ↗

RECRUITINGphase readoutNCT05266976: Mode of Exercise and Bone Biomarkers in Older Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Aging, Musculoskeletal Diseases, Osteoporosis

full page →ctgov ↗

COMPLETEDphase readoutNCT06719076: IMPACT OF DIABETES HEALTHCARE PROGRAM ON GLYCEMIC CONTROL, SELF-EFFICACY AND DIABETES KNOWLEDGE AMONG TYPE-II DIABETICS IN ISLAMABAD PAKISTAN

Sponsor: Health Services Academy, Islamabad, Pakistan. Phase: NA. Conditions: HbA1c, Self-Efficacy, Diabetes Knowledge

full page →ctgov ↗

RECRUITINGphase readoutNCT07228117: GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Sponsor: Medtronic MiniMed, Inc.. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07485517: Deep Versus Moderate Neuromuscular Blocking

Sponsor: Menoufia University. Phase: NA. Conditions: Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07373717: Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock

Sponsor: Southeast University, China. Phase: . Conditions: Shock

full page →ctgov ↗

COMPLETEDphase readoutNCT06695117: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04386317: Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT05245617: Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb

Sponsor: Orthofix s.r.l.. Phase: . Conditions: Deformity, Defect, Congenital, Trauma

full page →ctgov ↗

RECRUITINGphase readoutNCT06691217: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Vascular Inflammation, ASCVD, ASCVD Management

full page →ctgov ↗

TERMINATEDphase readoutNCT04587440: Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Coxarthrosis; Primary, Coxarthrosis; Secondary

full page →ctgov ↗

RECRUITINGphase readoutNCT07290140: Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Sponsor: Airiver Medical, Inc.. Phase: NA. Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

full page →ctgov ↗

COMPLETEDphase readoutNCT05861089: Rest PETCO2 as a Predictor of Post-operative Complications

Sponsor: St. Anne's University Hospital Brno, Czech Republic. Phase: . Conditions: Post-Op Complication

full page →ctgov ↗

RECRUITINGphase readoutNCT06163989: Protecting the Eyes of Gamers With Lubricating Eyedrops

Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Computer Vision Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07428889: Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

Sponsor: Shaklee Corporation. Phase: NA. Conditions: Healthy Adult

full page →ctgov ↗

RECRUITINGphase readoutNCT00801489: Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, de Novo Myelodysplastic Syndrome, High Risk Myelodysplastic Syndrome, Inv(16), Myelodysplastic Syndrome With Excess Blasts, t(16;16), t(8;21), Untreated Adult Acute Myeloid Leukemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06005168: Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

Sponsor: University of Michigan. Phase: PHASE4. Conditions: Surgical Prophylaxis

full page →ctgov ↗

RECRUITINGphase readoutNCT05277168: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07506668: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Sponsor: Affiliated Hospital of Nantong University. Phase: PHASE1. Conditions: Relapsed/Refractory B-cell Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT03896568: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma

full page →ctgov ↗

Date TBD